Dynamic Light Scattering: A Tool to Accelerate Oncolytic Vaccine Development
This case study highlights the significance of particle size analysis via Dynamic Light Scattering (DLS) in the development of vaccines based on the MVA virus.
Cutting edge process development insights and news from APC.
This case study highlights the significance of particle size analysis via Dynamic Light Scattering (DLS) in the development of vaccines based on the MVA virus.
Irish R&D firm APC partners with Australian biotech Vaxine to speed up COVID-19 vaccine candidate development, accelerating the time to patients.